logo-loader
viewWatches of Switzerland Group PLC

Watches of Switzerland ticking along nicely as interim profits more than double

WoS also revealed it was paying almost £32mln for showrooms in Stratford, Brent Cross, Kingston and York from Fraser Hart

Watches of Switzerland Group PLC -

Watches of Switzerland PLC (LON:WOSG) shares moved higher on Tuesday as the retailer appears to be ticking along quite nicely judging from its interim results.

The luxury watch stores group, which also announced the acquisition of four new showrooms, said adjusted profits more than doubled to £26.5mln. Forgetting the financial finagling, underlying earnings, also known as EBITDA, were up 23.5% to £41.2mln, reflecting a rise in operating profit margins to 9.6%.

The performance was achieved on a 17.3% lift to turnover to £428.7mln, with luxury watch sales 85% of total revenues. Rolex demand continued to outstrip supplies, WoS said.

The company’s June IPO brought in net proceeds of around £148mln, the majority of which was used to pay off debts which at the October 27 period-end stood at a ‘net’ £92.1mln (down from £235mln).

The company also generated net cash of almost £50mln.

In a separate announcement, WoS said it was paying almost £32mln for showrooms in Stratford, Brent Cross, Kingston and York from Fraser Hart. The operations turned over £25.7mln last year.

In a note to clients following the numbers, analysts at Barclays raised their pre-tax profit forecasts by 2% for 2020 and 7% for 2021, upped their target price for Watches of Switzerland shares to 360p from 325p and reiterated an 'overweight' stance on the stock.

In late morning trading, Watches of Switzerland shares were 0.2% higher at 324.60p.

 -- Adds broker comment, share price --

 

Quick facts: Watches of Switzerland Group PLC

Price: 387.6 GBX

LSE:WOSG
Market: LSE
Market Cap: £928.09 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Revenue guidance from OptiBiotix as it eyes NASDAQ listing

OptiBiotix Health (LON:OPTI) provides a commercial progress update, explaining why in their financials some items are separated. CEO Stephen O'Hara tells Proactive London what's behind his thinking adding that Optibiotix hopes to reach profitability in 2020. News here too on Sweetbiotix and...

1 day, 17 hours ago

RNS

Holding(s) in Company

2 days, 18 hours ago

Holding(s) in Company

3 days, 13 hours ago

Holding(s) in Company

4 days, 16 hours ago

Price Monitoring Extension

3 weeks, 2 days ago

2 min read